Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/north central cancer treatment group study n0074

Joon H. Uhm, Karla V. Ballman, Wenting Wu, Caterina Giannini, J. C. Krauss, Jan C. Buckner, C. D. James, Bernd W. Scheithauer, Robert J. Behrens, Patrick J. Flynn, Paul L. Schaefer, Shaker R. Dakhill, Kurt A. Jaeckle

Research output: Contribution to journal › Article › peer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/north central cancer treatment group study n0074'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology